Skip to content
Screener

Stock-Based Comp at other companies

Eli Lilly logo
Eli LillyLLY
$201M+8.6%
AbbVie logo
AbbVieABBV
$444M+8.3%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$312K-30.8%
Establishment Labs logo
Establishment LabsESTA
$3.23M-4.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$52M+20.9%

Other financials

Income statement

See full
Revenue$42.9M-2.5%
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038
Line itemSix Months Ended June 30,Six Months Ended June 30,Six Months Ended June 30,Six Months Ended June 30,
Net loss$$(3,509)$$(3,438)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization5,9626,488
Equity-based compensation1,4712,591
Non-cash interest expense; amortization of debt costs273242
Loss on impairment of long-lived assets108
Changes in assets and liabilities
Taxes receivable(863)1,251

Item 1. Financial Statements

FAQ

What is AirSculpt Technologies, Inc.'s stock-based comp?
AirSculpt Technologies, Inc. (AIRS) reported stock-based comp of $912K in Q2 2026.
How has AirSculpt Technologies, Inc.'s stock-based comp changed year-over-year?
AirSculpt Technologies, Inc.'s stock-based comp decreased by 32.5% year-over-year, from $1.35M to $912K.
What is the long-term trend for AirSculpt Technologies, Inc.'s stock-based comp?
Over 3 years (2021 to 2024), AirSculpt Technologies, Inc.'s stock-based comp has grown at a -19.4% compound annual growth rate (CAGR), from $7.19M to $3.76M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about AirSculpt Technologies, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude